Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133998132> ?p ?o ?g. }
- W3133998132 endingPage "1485" @default.
- W3133998132 startingPage "1485" @default.
- W3133998132 abstract "Ezetimibe (EZE) possesses low aqueous solubility and poor bioavailability and in addition, its extensive hepatic metabolism supports the notion of developing a novel carrier system for EZE. Ezetimibe was encapsulated into nanostructured lipid carriers (EZE-NLCs) via a high pressure homogenization technique (HPH). A three factor, two level (23) full factorial design was employed to study the effect of amount of poloxamer 188 (X1), pressure of HPH (X2) and number of HPH cycle (X3) on dependent variables. Particle size, polydispersity index (PDI), % entrapment efficiency (%EE), zeta potential, drug content and in-vitro drug release were evaluated. The optimized formulation displays pragmatic inferences associated with particle size of 134.5 nm; polydispersity index (PDI) of 0.244 ± 0.03; zeta potential of −28.1 ± 0.3 mV; % EE of 91.32 ± 1.8% and % CDR at 24-h of 97.11%. No interaction was observed after X-ray diffraction (XRD) and differential scanning calorimetry (DSC) studies. EZE-NLCs (6 mg/kg/day p.o.) were evaluated in the high fat diet fed rats induced hyperlipidemia in comparison with EZE (10 mg/kg/day p.o.). Triglyceride, HDL-c, LDL-c and cholesterol were significantly normalized and histopathological evaluation showed normal structure and architecture of the hepatocytes. The results demonstrated the superiority of EZE-NLCs in regard to bioavailability enhancement, dose reduction and dose-dependent side effects." @default.
- W3133998132 created "2021-03-15" @default.
- W3133998132 creator A5008387075 @default.
- W3133998132 creator A5015791582 @default.
- W3133998132 creator A5023622012 @default.
- W3133998132 creator A5028963411 @default.
- W3133998132 creator A5043082541 @default.
- W3133998132 creator A5043101917 @default.
- W3133998132 creator A5063029157 @default.
- W3133998132 creator A5090598099 @default.
- W3133998132 date "2021-03-09" @default.
- W3133998132 modified "2023-10-16" @default.
- W3133998132 title "Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet" @default.
- W3133998132 cites W1650965741 @default.
- W3133998132 cites W1691203925 @default.
- W3133998132 cites W1714765228 @default.
- W3133998132 cites W1916833867 @default.
- W3133998132 cites W1968977462 @default.
- W3133998132 cites W1972753189 @default.
- W3133998132 cites W1976779766 @default.
- W3133998132 cites W1977755432 @default.
- W3133998132 cites W1980535921 @default.
- W3133998132 cites W1981758784 @default.
- W3133998132 cites W1993416244 @default.
- W3133998132 cites W2007327214 @default.
- W3133998132 cites W2027889438 @default.
- W3133998132 cites W2040685164 @default.
- W3133998132 cites W2046017386 @default.
- W3133998132 cites W2052837798 @default.
- W3133998132 cites W2062297205 @default.
- W3133998132 cites W2077925518 @default.
- W3133998132 cites W2079407952 @default.
- W3133998132 cites W2083796174 @default.
- W3133998132 cites W2109081474 @default.
- W3133998132 cites W2155197175 @default.
- W3133998132 cites W2265120954 @default.
- W3133998132 cites W2312243875 @default.
- W3133998132 cites W2328898794 @default.
- W3133998132 cites W2472983148 @default.
- W3133998132 cites W2547070871 @default.
- W3133998132 cites W2617995958 @default.
- W3133998132 cites W2620373091 @default.
- W3133998132 cites W2626406601 @default.
- W3133998132 cites W2738817678 @default.
- W3133998132 cites W2782201864 @default.
- W3133998132 cites W2789243161 @default.
- W3133998132 cites W2792880867 @default.
- W3133998132 cites W2810248278 @default.
- W3133998132 cites W2904572694 @default.
- W3133998132 cites W2922215129 @default.
- W3133998132 cites W2922428194 @default.
- W3133998132 cites W2927771003 @default.
- W3133998132 cites W2978061681 @default.
- W3133998132 cites W2984384571 @default.
- W3133998132 cites W3001764054 @default.
- W3133998132 cites W3011988854 @default.
- W3133998132 cites W3012817514 @default.
- W3133998132 cites W3039300704 @default.
- W3133998132 cites W3094650461 @default.
- W3133998132 doi "https://doi.org/10.3390/molecules26051485" @default.
- W3133998132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7967240" @default.
- W3133998132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33803259" @default.
- W3133998132 hasPublicationYear "2021" @default.
- W3133998132 type Work @default.
- W3133998132 sameAs 3133998132 @default.
- W3133998132 citedByCount "6" @default.
- W3133998132 countsByYear W31339981322021 @default.
- W3133998132 countsByYear W31339981322022 @default.
- W3133998132 countsByYear W31339981322023 @default.
- W3133998132 crossrefType "journal-article" @default.
- W3133998132 hasAuthorship W3133998132A5008387075 @default.
- W3133998132 hasAuthorship W3133998132A5015791582 @default.
- W3133998132 hasAuthorship W3133998132A5023622012 @default.
- W3133998132 hasAuthorship W3133998132A5028963411 @default.
- W3133998132 hasAuthorship W3133998132A5043082541 @default.
- W3133998132 hasAuthorship W3133998132A5043101917 @default.
- W3133998132 hasAuthorship W3133998132A5063029157 @default.
- W3133998132 hasAuthorship W3133998132A5090598099 @default.
- W3133998132 hasBestOaLocation W31339981321 @default.
- W3133998132 hasConcept C101335993 @default.
- W3133998132 hasConcept C105795698 @default.
- W3133998132 hasConcept C11432220 @default.
- W3133998132 hasConcept C121332964 @default.
- W3133998132 hasConcept C134018914 @default.
- W3133998132 hasConcept C13965031 @default.
- W3133998132 hasConcept C147789679 @default.
- W3133998132 hasConcept C155574463 @default.
- W3133998132 hasConcept C155672457 @default.
- W3133998132 hasConcept C15920480 @default.
- W3133998132 hasConcept C169222746 @default.
- W3133998132 hasConcept C171250308 @default.
- W3133998132 hasConcept C178790620 @default.
- W3133998132 hasConcept C181389837 @default.
- W3133998132 hasConcept C185592680 @default.
- W3133998132 hasConcept C187530423 @default.
- W3133998132 hasConcept C192562407 @default.
- W3133998132 hasConcept C2778163477 @default.
- W3133998132 hasConcept C2778657065 @default.